ARCHIVES

NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals

This article is from The Cancer Letter archive.

Vol. 16 No. 07 | February 16, 1990

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

How NCI Would Apportion New Round Of budget Cuts- 1980 $17 Million, 1981 $42.7 Million

April 11, 1980

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975